Understanding the Medication Classification of Isocarboxazid
•
3 min read
Isocarboxazid, an older antidepressant approved in the US in 1959, belongs to a medication classification known as monoamine oxidase inhibitors (MAOIs). While its use has declined due to newer antidepressants with fewer side effects, it remains a valuable option for certain cases of severe depression resistant to other treatments.
